Advanced sequencing technologies, the growing demand for precision medicine, and application-specific genomic analysis are expected to shape the next phase of growth in the DNA sequencing market. The global DNA sequencing market is projected to grow at a CAGR of 22% by 2031, creating new opportunities for sequencing platform manufacturers, diagnostic companies, biotechnology firms, and …
Growing drug-launch complexity, expanding market-access requirements, and increasing demand for outsourced commercialization services are creating an attractive investment opportunity in the pharma CCO market. The pharmaceutical industry is entering a period in which commercialization is becoming increasingly complex. The rise of specialty and orphan drugs, more demanding market-access requirements, growing evidence expectations, and the need …
Sub-Saharan Africa’s pharmaceutical market is projected to grow from approximately $8 billion in 2025 to $13 billion by 2030, supported by rising healthcare demand, increasing access to medicines and efforts to expand pharmaceutical manufacturing across the region, according to Medi-Tech Insights. The Sub-Saharan Africa pharmaceuticals market is forecast to expand at a 10.2% CAGR from …
Global Doorstep Treatment Market was valued at USD 425.2 billion in 2025 and is projected to grow at a 6.2% CAGR from 2026 to 2035, supported by rising demand for convenient, technology-enabled healthcare services delivered at home. The healthcare industry is witnessing a continued shift toward decentralized care as patients increasingly seek medical services that …
AI healthcare company Forus has raised $150 million in Series C financing, bringing its valuation to $3 billion as the company expands its artificial intelligence-powered healthcare network designed to help connect physicians, patients, pharmacies, insurers and biopharmaceutical companies. The latest financing marks a significant increase in Forus’ valuation. The company has tripled its valuation in …
Medtronic has raised its fiscal 2027 revenue-growth forecast and increased the lower end of its adjusted earnings outlook after reporting strong first-quarter demand across its cardiovascular portfolio. The medical technology company said on September 1 that it now expects organic revenue growth of 7.25% to 7.75%, compared with its previous forecast of 6.75% to 7.25%. …
Surrogacy can provide a family-building route when pregnancy is impossible, medically unsafe, or biologically unavailable to an intended parent. It may be considered by people with uterine-factor infertility, some cancer survivors, male same-sex couples, single intended fathers, and others after individualized medical and legal review. Accurate information matters because surrogacy combines assisted reproductive technology, pregnancy …
Zydus Lifesciences’ first-quarter net profit declined 35.9% to ₹9.40 billion, despite strong revenue growth. Revenue from operations increased 22% to ₹80.17 billion, supported by India formulations, international markets and consumer wellness. EBITDA fell 7.6%, while the EBITDA margin narrowed sharply to 24.1% from 31.8% a year earlier. India-based Zydus Lifesciences reported a 35.9% decline in …
The Peptide CDMO Market is gaining strategic importance as pharmaceutical and biotechnology companies increase their investment in peptide-based therapeutics. Rapid growth in GLP-1 medicines, expanding cardiometabolic pipelines and the development of next-generation peptide drugs are creating substantial demand for specialized manufacturing capacity. According to Medi-Tech Insights, the Peptide CDMO Market is projected to grow at …
Germany’s Merck KGaA raised its 2026 profit guidance after second-quarter adjusted earnings exceeded expectations, supported by stronger demand in its Life Science and Electronics businesses and easing currency pressure. The Darmstadt-based science and technology group now expects adjusted earnings before interest, taxes, depreciation and amortisation, or EBITDA, of €5.9 billion to €6.3 billion in 2026. …